Edward Fox

Detection of ultra-rare mutations by next-generation sequencing

Michael W. Schmitt, Scott R. Kennedy, Jesse J. Salk et al. · Proceedings of the National Academy of Sciences · 2012 · 1.1K citations · Full text

Life Sciences, Genetics, Molecular Biology +15

Detecting ultralow-frequency mutations by Duplex Sequencing

Scott R. Kennedy, Michael W. Schmitt, Edward Fox et al. · Nature Protocols · 2014 · 539 citations · Full text

Medicine, Genetics, Molecular Genetics +9

Phase IIB Trial of Oral Midostaurin (PKC412), the FMS-Like Tyrosine Kinase 3 Receptor (FLT3) and Multi-Targeted Kinase Inhibitor, in Patients With Acute Myeloid Leukemia and High-Risk Myelodysplastic Syndrome With Either Wild-Type or Mutated FLT3

Thomas Fischer, Richard M. Stone, Daniel J. DeAngelo et al. · Journal of Clinical Oncology · 2010 · 502 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Accuracy of Next Generation Sequencing Platforms

Edward Fox, Kate S. Reid-Bayliss · Journal of Next Generation Sequencing & Applications · 2014 · 222 citations · Full text

Life Sciences, Bioinformatics, Molecular Biology +12

Ublituximab versus Teriflunomide in Relapsing Multiple Sclerosis

Lawrence Steinman, Edward Fox, Hans‐Peter Hartung et al. · New England Journal of Medicine · 2022 · 199 citations

Life Sciences, Immunology, Pharmacotherapy +17